# FDA 483 - Brian B. Borg, M.D. - September 01, 2023

Source: https://www.keypedia.com/records/483/brian-b-borg-md/59f58a2f-aa0c-41af-b428-45c3a2a4840f

> FDA 483 for Brian B. Borg, M.D. on September 01, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Brian B. Borg, M.D.
- Inspection Date: 2023-09-01
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: An FDA inspection of Brian B. Borg, M.D., a clinical investigator, revealed significant deviations in the conduct of a clinical investigation. The firm failed to adhere to the investigational plan, resulting in subjects receiving incorrect investigational product and improper infusion times. Additionally, the firm lacked adequate records for investigational drug disposition.

## Related Officers

- [Christopher M. Jeffers](https://www.keypedia.com/people/christopher-m-jeffers/327faaff-619a-4180-ab4c-b5f1b5ba84be)
- [investigator](https://www.keypedia.com/people/kellie-r-riggs/556818c6-eb9a-48a5-9630-aba7a807ec07)

Company: https://www.keypedia.com/companies/brian-b-borg-md/ea7e9c31-dcb5-4bda-ba65-737b097e5571

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea